Ocular Surface Disease

Self-reported visual difficulty had a limited ability to identify adults with objectively measured visual impairment, according to an analysis of data from a nationally representative sample of Medicare beneficiaries.

Scleral lenses demonstrated safety and efficacy for treating ocular surface disease and irregular cornea/refractive conditions in children, according to an approximately 2-decade long study published in Clinical Optometry.

KOLOA, Hawaii — With appropriate IOL selection, careful preoperative assessment and accurate calculations, presbyopia-correcting IOLs can be successful in patients who previously underwent corneal refractive surgery, according to a speaker.

INDIANAPOLIS — Verséa Ophthalmics recently has introduced several new technologies for eye care, including the Biovance 3L Ocular amniotic membrane allograft and the T-POC quantitative testing platform for ocular surface disease.

INDIANAPOLIS — Progression of ocular surface disease appears significant among young adults, including those who wear contact lenses, with screen time and stress reported to be modifiable risk factors, according to a presenter.

CHICAGO — In this Healio Video Perspective from the AAO meeting, Neel R. Desai, MD, of The Eye Institute of West Florida discusses the positive impact of the TearCare system on ocular surface disease and meibomian gland dysfunction.

For many years, I have seen older patients with obvious meibomian gland dysfunction at the lid margin, often combined with blepharitis. Their gland openings are problematic, but when we do meibography, the internal glands are intact.

Don’t try to convince yourself otherwise. We are all guilty. Much of our clinical practice of eye care is deeply entrenched in habit — and for good reason.